Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease

Molecular and Cellular Proteomics - United States
doi 10.1074/mcp.m112.017640
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer

PLoS ONE
Multidisciplinary
2013English

Proteomic Profiling for the Identification of Serum Diagnostic Biomarkers for Abdominal and Thoracic Aortic Aneurysms

Proteome Science
BiochemistryMolecular Biology
2013English

A Quantitative Proteomic Approach for Identification of Potential Biomarkers in Hepatocellular Carcinoma

Journal of Proteome Research
BiochemistryChemistry
2008English

Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis

PLoS ONE
Multidisciplinary
2013English

Quantitative Proteomic Analysis by iTRAQ® for the Identification of Candidate Biomarkers in Ovarian Cancer Serum

Proteome Science
BiochemistryMolecular Biology
2010English

Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2020English

Identification of Novel Protein Biomarkers of Preterm Birth in Human Cervical-Vaginal Fluid

English

Screening for Specific Biomarkers in the Serum of Postmenopausal Osteoporosis Patients Using Proteomic Fingerprint Techniques

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2012English

Identification of Novel Biomarkers in Chronic Immune Thrombocytopenia (ITP) by Microarray-Based Serum Protein Profiling

British Journal of Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy